Pfizer INC 13F institutional holdings

Quarterly disclosures of US equity positions held by institutional managers with over $100 million under management.

NYSE
Pfizer Inc. filed its Form 13F for the quarter ended March 31, 2026, detailing its institutional investment holdings.
NYSE
Pfizer Inc. has filed its Form 13F-HR, revealing its equity holdings totaling over $236 million across 21 positions as of December 31, 2025.
NYSE
Pfizer Inc. filed its Form 13F-HR, revealing its equity holdings totaling over $437 million as of September 30, 2025.
NYSE
Pfizer Inc. has filed its Form 13F-HR, revealing its institutional investment holdings totaling over $576 million as of June 30, 2025.
NYSE
Pfizer Inc. reports its holdings for the quarter ended March 31, 2025, with a total portfolio value of approximately $500.8 million across 24 holdings.
NYSE
Pfizer Inc's latest 13F filing discloses a diverse investment portfolio with a total value of over $2.5 billion as of December 31, 2024.